These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31183782)

  • 41. Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren's syndrome dry eye disease.
    Sloesen B; Young A; Forde K; Hodson N; Bentley S; Walsh O; Naujoks C; O'Brien P; Sharma G
    J Patient Rep Outcomes; 2023 Jul; 7(1):64. PubMed ID: 37405617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
    Matza LS; Stewart KD; Naegeli AN; Mills KM; Coyne KS; Chew KW; Hughes MD; Smith DM
    J Patient Rep Outcomes; 2023 Jan; 7(1):8. PubMed ID: 36719546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey.
    Siggelkow H; Clarke BL; Germak J; Marelli C; Chen K; Dahl-Hansen H; Glenister E; Bent-Ennakhil N; Judge D; Mycock K; Bollerslev J
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):159-168. PubMed ID: 31721256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.
    Tatlock S; Rüdell K; Panter C; Arbuckle R; Harrold LR; Taylor WJ; Symonds T
    Patient; 2017 Feb; 10(1):65-79. PubMed ID: 27384670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.
    Lipton RB; Gandhi P; Stokes J; Cala ML; Evans CJ; Knoble N; Gelhorn HL; Revicki D; Viswanathan HN; Dodick DW
    Headache; 2022 Jan; 62(1):89-105. PubMed ID: 34962305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE with lupus nephritis (LN).
    Williams-Hall R; Berry P; Williamson N; Barclay M; Roberts A; Gater A; Tolley C; Bradley H; Ward A; Hsia E; Zuraw Q; DeLong P; Touma Z; Strand V
    Lupus Sci Med; 2022 Aug; 9(1):. PubMed ID: 36007978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD).
    Taylor F; Higgins S; Carson RT; Eremenco S; Foley C; Lacy BE; Parkman HP; Reasner DS; Shields AL; Tack J; Talley NJ;
    Am J Gastroenterol; 2018 Jan; 113(1):39-48. PubMed ID: 28925989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures.
    Mathias SD; Berry P; De Vries J; Pascoe K; Colwell HH; Chang DJ; Askanase AD
    J Patient Rep Outcomes; 2017; 2(1):11. PubMed ID: 29757295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Content validation of a daily patient-reported outcome measure for assessing symptoms in patients with Small Intestinal Bacterial Overgrowth.
    Durgam N; Dashputre AA; Moshkovich O; Rezaie A; Martinez N; Enayati P; Stansbury J; Joseph G
    Qual Life Res; 2023 Sep; 32(9):2573-2585. PubMed ID: 37212941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of the Impact of Nighttime Urination (INTU) questionnaire to assess the impact of nocturia on health and functioning.
    Abrams S; Martin S; Gillard KK; Cheng L; Fein S
    Neurourol Urodyn; 2018 Jun; 37(5):1686-1692. PubMed ID: 29566269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS
    Findley A; Middlehurst JM; Howse CA; Clifford MJ; Neill W; Tatlock S; Chen WH; Bracher MG; Patel DS
    J Patient Rep Outcomes; 2023 Apr; 7(1):39. PubMed ID: 37079188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
    Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
    BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an overactive bladder assessment tool (BAT): A potential improvement to the standard bladder diary.
    Kelleher C; Chapple C; Johnson N; Payne C; Homma Y; Hakimi Z; Siddiqui E; Evans C; Egan S; Kopp Z
    Neurourol Urodyn; 2018 Jun; 37(5):1701-1710. PubMed ID: 29360189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.
    Mannix S; Skalicky A; Buse DC; Desai P; Sapra S; Ortmeier B; Widnell K; Hareendran A
    Health Qual Life Outcomes; 2016 Oct; 14(1):143. PubMed ID: 27716228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.
    Rydén A; Nolan S; Maher J; Meyers O; Kündig A; Bjursell M
    BMC Nephrol; 2022 Jun; 23(1):201. PubMed ID: 35641914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validity.
    Morris S; Li Y; Smith JAM; Dube' S; Burbridge C; Symonds T
    BMC Musculoskelet Disord; 2017 May; 18(1):195. PubMed ID: 28511678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary.
    Gater A; Nelsen L; Fleming S; Lundy JJ; Bonner N; Hall R; Marshall C; Staunton H; Krishnan JA; Stoloff S; Schatz M; Haughney J;
    Value Health; 2016 Jun; 19(4):440-50. PubMed ID: 27325336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS).
    Foley C; Tundia N; Simpson E; Teixeira HD; Litcher-Kelly L; Bodhani A
    Curr Med Res Opin; 2019 Jul; 35(7):1139-1148. PubMed ID: 30561230
    [No Abstract]   [Full Text] [Related]  

  • 60. Development and content validation of a patient-reported endometriosis pain daily diary.
    van Nooten FE; Cline J; Elash CA; Paty J; Reaney M
    Health Qual Life Outcomes; 2018 Jan; 16(1):3. PubMed ID: 29301557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.